Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review

QR Code

Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review

At present, there is no evidence based pathway to stratify risk of chronic liver disease in a general population setting. Non-invasive tests of liver fibrosis may provide a mechanism for earlier diagnosis. These tests have been extensively validated in the hospital setting but their performance in a...

Full description

Bibliographic Details
Main Authors:	Harris, Rebecca, Harman, David J., Card, Timothy R., Aithal, Guruprasad P., Guha, Indra Neil
Format:	Article
Published:	Elsevier 2017
Subjects:	Chronic liver disease risk stratification community non-invasive test
Online Access:	https://eprints.nottingham.ac.uk/40240/

Similar Items

Risk stratification of chronic liver disease in the community
by: Harris, Rebecca
Published: (2019)

Biomarkers of liver fibrosis
by: Morling, Joanne R., et al.
Published: (2016)

The identification of chronic liver disease in primary care using non-invasive diagnostics within a novel pathway
by: Harman, David J.
Published: (2017)

Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using Transient Elastography
by: Harman, David J., et al.
Published: (2018)

Analysis of genotyping for predicting liver injury marker, Procollagen III in persons at risk of non-alcoholic fatty liver disease
by: Grove, Jane I., et al.
Published: (2018)

ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
by: Daniels, Samuel J., et al.
Published: (2018)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)

The effect of circulatory dysfunction upon the liver in haemodialysis patients
by: Grant, Claire
Published: (2019)

SOX9 predicts progression towards cirrhosis in patients while its loss protects against liver fibrosis
by: Athwal, Varinder S., et al.
Published: (2017)

Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: a randomized crossover study
by: Bawden, Stephen, et al.
Published: (2016)

The histomorphological analysis of liver following administration of low doses of diclofenac and ibuprofen
by: Mohanambal, Moorthy, et al.
Published: (2009)

Biomarkers to predict advanced liver diseases
by: Alenezi, Yusef
Published: (2024)

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
by: Harman, David J., et al.
Published: (2015)

Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study
by: Tanajewski, Lukasz, et al.
Published: (2017)

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study
by: Morling, Joanne R., et al.
Published: (2014)

Biomarkers of drug-induced liver injury
by: Atallah, Edmond
Published: (2024)

Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses
by: Tirnitz-Parker, Nina, et al.
Published: (2014)

Liver segmentation on CT images using random walkers and fuzzy c-means for treatment planning and monitoring of tumors in liver cancer patients
by: Moghbel, Mehrdad
Published: (2017)

Detection of liver injury in IBD using Transient Elastography
by: Thin, L., et al.
Published: (2014)

Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification
by: Aleskandarany, Mohammed A., et al.
Published: (2015)

Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection
by: He, Jun-Jun, et al.
Published: (2016)

Microsphere distribution and radiation dosimetry in human liver following Yttrium-90 microsphere therapy.
by: Campbell, Andrew M.
Published: (2000)

The study of troglitazone liver toxicity via in vitro and in silico approaches
by: Nuamah, M.F
Published: (2022)

Variation in clearance and invasiveness of pharmacokinetic studies in children
by: Altamimi, Mohammed Ibrahim
Published: (2016)

Exploring molecular portraits defining lymphovascular invasion in invasive breast cancer patients
by: Sonbul, Sultan Naeem M.
Published: (2019)

The effect of pretreatment of zerumbone on fatty liver following ethanol induced Hepatotoxicity
by: Fakurazi, Sharida, et al.
Published: (2008)

Liver cirrhosis in England--an observational study: are we measuring its burden occurrence correctly?
by: Ratib, Sonia, et al.
Published: (2017)

Campylobacters and their bacteriophages from chicken liver: the prospect for phage biocontrol
by: Firlieyanti, Antung S., et al.
Published: (2016)

Pharmacogenomics of drug-induced liver injury (DILI): molecular biology to clinical applications
by: Kaliyaperumal, Kalaiyarasi, et al.
Published: (2018)

Antiproliferative effects of zerumbone-hydroxypropyl-ß-cyclodextrin inclusion complex on HepG2 liver cancer cells in vitro
by: Muhammad Nadzri, Nabilah
Published: (2013)

Liver progenitor cell interactions with the extracellular matrix
by: Zhu, C., et al.
Published: (2012)

Isoaspartate, Carbamoyl phosphate synthase-1, and carbonic anhydrase-III as biomarkers of liver injury
by: Carter, Wayne, et al.
Published: (2016)

Lower Fructose Intake May Help Protect Against Development of Nonalcoholic Fatty Liver in Adolescents With Obesity
by: O'Sullivan, T., et al.
Published: (2014)

Hip fracture risk in patients with alcoholic cirrhosis: a population-based study using English and Danish data
by: Otete, Harmony E., et al.
Published: (2018)

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
by: Friedman, Scott L., et al.
Published: (2018)

Seroepidemiology of Toxoplasma gondii infection in patients with liver disease in eastern China
by: Tian, A.L., et al.
Published: (2017)

Deciphering a molecular mechanism underlying lymphovascular invasion in breast cancer
by: Aljohani, Abrar
Published: (2022)

From semi-synthetic to natural biomaterials: a journey to the development of an optimized in-vitro model for liver tissue engineering
by: Tarsitano, Elisa
Published: (2022)

The role of intramyocellular lipid content in the physiological changes observed in inactivity, exercise, and non-alcoholic fatty liver disease
by: Chivaka, Prince
Published: (2023)

Effects of CXCR4 Silencing by Sirna Engrafted Cotionized Dextran in Mouse Models of Colorectal Cancer and Liver Metastasis
by: Abedini, Fatemeh
Published: (2011)